渤健Biogen (BIIB) 2006年年度报告「NASDAQ」.pdf

1、PATIENTS ARE OUR PURPOSE2006 ANNUAL REPORTMarilyn Lewis RITUXAN RA patientBarbara Sales TYSABRI patientSAFE HARBOR This Annual Report contains forward-looking statements regarding expected future financial results,the size and growth of the markets for our products,and plans for our product developm

2、ent programs.Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from that which we expect.Important factors that could cause our actual results to differ include our continued dependence on our two principal products,the uncertainty

3、 of success in commercializing other products including the launch of TYSABRI,the occurrence of adverse safety events with our products,the failure to execute our growth strategy successfully or to compete effectively in our markets,our dependence on collaborations over which we may not always have

4、full control,possible adverse impact of government regulation and changes in the availability of reimbursement for our products,problems with our manufacturing processes and our reliance on third parties,fluctuations in our operating results,our ability to protect our intellectual property rights an

5、d the cost of doing so,the risks of doing business internationally and the other risks and uncertainties that are described in our filings with the Securities and Exchange Commission,including our Annual Report on Form 10-K filed in February,2007.These forward-looking statements speak only as of the

6、 date of this Annual Report,and we do not undertake any obligation to publicly update any forward-looking statements,whether as a result of new information,future events,or otherwise.All of the Companys SEC filings are available at the SECs website,www.sec.gov,or upon request from the Companys Inves